GRI BIO INC has a total of 28 patent applications. It decreased the IP activity by 40.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, environmental technology and organic fine chemistry are NEURODYN LIFE SCIENCES INC, EPITECH GROUP SRL and SUCAMPO AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 6 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Mexico | 2 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 | |
#11 | Japan | 1 | |
#12 | Russian Federation | 1 | |
#13 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Chaturvedi Vipin Kumar | 14 |
#2 | Friedrichson Tim | 9 |
#3 | Schlechtingen Georg | 9 |
#4 | Jennings Gary | 9 |
#5 | Braxmeier Tobias | 9 |
#6 | Knölker Hans-Joachim | 5 |
#7 | Vipin Kumar Chaturvedi | 4 |
#8 | Knolker Hans-Joachim | 4 |
Publication | Filing date | Title |
---|---|---|
CA3007970A1 | Prevention and treatment of inflammatory conditions | |
RU2678561C2 | Prevention and treatment of inflammatory conditions | |
EP2809648A1 | Oxygenated amino- or ammonium-containing sulfonic acid derivatives and their medical use | |
EP3610868A1 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use |